How Do You Spell CONGENITAL AFIBRINOGENEMIA?

Pronunciation: [kənd͡ʒˈɛnɪtə͡l ɐfˌɪbɹɪnə͡ʊd͡ʒnˈiːmi͡ə] (IPA)

Congenital Afibrinogenemia is a rare genetic bleeding disorder, characterized by the absence or reduced levels of fibrinogen in the blood. The spelling of "Congenital Afibrinogenemia" can be explained in the International Phonetic Alphabet (IPA) as /kənˈdʒɛnɪtəl ˌeɪfɪbrɪnoʊdʒəˈniːmiə/. The word starts with a stress on the first syllable, followed by a schwa sound in the second syllable. The third syllable has the long "a" sound before the consonant cluster "fibrin". The final syllables include the stressed "no" and "mia".

CONGENITAL AFIBRINOGENEMIA Meaning and Definition

1. Congenital afibrinogenemia is a rare and serious inherited blood disorder characterized by the absence or severe deficiency of fibrinogen in the blood. Fibrinogen is a protein essential for blood clotting, and its absence or low levels result in impaired coagulation and an increased risk of bleeding.

   This condition is present from birth and is caused by mutations in one or more of the three genes involved in the production of fibrinogen. These mutations disrupt the normal synthesis or structure of fibrinogen, leading to its complete absence or reduced levels.

   Individuals with congenital afibrinogenemia commonly experience bleeding episodes, which can be spontaneous or occur after trauma or invasive procedures. The severity and frequency of bleeding episodes can vary between individuals, ranging from mild to life-threatening. Common symptoms include prolonged bleeding from the nose, gums, or skin, heavy or prolonged menstruation, and excessive bleeding after dental work or surgeries.

   Diagnosis of congenital afibrinogenemia is based on clinical presentation, family history, and laboratory tests that measure fibrinogen levels in the blood. The condition can be confirmed by genetic testing, which identifies the specific gene mutations responsible for the disorder.

   Treatment of congenital afibrinogenemia mainly focuses on preventing or managing bleeding episodes. This typically involves administering fibrinogen replacement therapy, either by infusing purified fibrinogen concentrates or fresh frozen plasma. In addition, individuals with this condition are advised to take measures to prevent bleeding injuries and maintain good oral hygiene to reduce the risk of spontaneous bleeding episodes. Regular monitoring of the fibrinogen levels and overall health is important in managing this disorder.

Common Misspellings for CONGENITAL AFIBRINOGENEMIA

• xongenital afibrinogenemia
• vongenital afibrinogenemia
• fongenital afibrinogenemia
• dongenital afibrinogenemia
• cingenital afibrinogenemia
• ckngenital afibrinogenemia
• clngenital afibrinogenemia
• cpngenital afibrinogenemia
• c0ngenital afibrinogenemia
• c9ngenital afibrinogenemia
• cobgenital afibrinogenemia
• comgenital afibrinogenemia
• cojgenital afibrinogenemia
• cohgenital afibrinogenemia
• confenital afibrinogenemia
• convenital afibrinogenemia
• conbenital afibrinogenemia
• conhenital afibrinogenemia
• conyenital afibrinogenemia

Etymology of CONGENITAL AFIBRINOGENEMIA

The term "Congenital Afibrinogenemia" is derived from the following components:

1. Congenital: The word "congenital" comes from the Latin word "congenitus", which means "innate" or "existing from birth". In medical terminology, "congenital" is used to describe conditions present at or before birth.

2. Afibrinogenemia: The term "afibrinogenemia" is a combination of two elements: "a-" and "fibrinogenemia".

- The prefix "a-" is a negating prefix, indicating the absence or lack of something. In this case, it signifies the absence or lack of fibrinogen.

- Fibrinogen is a plasma protein that plays a crucial role in blood clotting.

Similar spelling word for CONGENITAL AFIBRINOGENEMIA

• congenital afibrinogenaemia.